Antonia Efstathiou
Athens, ESYE31 11521, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Editorial: New Strategies to Combat Antimicrobial Resistance in Infectious Diseases.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 31, 2026
Impact of the COVID-19 Pandemic on Drug-Resistant Tuberculosis in Europe: A Meta-Analysis of Epidemiological Trends.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 31, 2025
Deciphering European Sea Bass (Dicentrarchus labrax) Resistance to Nervous Necrosis Virus by Transcriptome Analysis from Early Infection Towards Establishment of Virus Carrier State.
Journal: International journal of molecular sciences
Published: July 30, 2025
Influence of Viral Re-Infection on Head Kidney Transcriptome of Nervous Necrosis Virus-Resistant and -Susceptible European Sea Bass (Dicentrarchus labrax, L.).
Journal: Viruses
Published: December 26, 2024
Serological Screening and Risk Factors Associated with Leishmania infantum Positivity in Newly Diagnosed HIV Patients in Greece.
Journal: Microorganisms
Published: June 10, 2024
Seroprevalence of Toxoplasma gondii among HIV Positive Patients under Surveillance in Greek Infectious Disease Units: A Screening Study with Comparative Evaluation of Serological Methods.
Journal: Pathogens (Basel, Switzerland)
Published: March 29, 2024
Nervous Necrosis Virus Modulation of European Sea Bass (Dicentrarchus labrax, L.) Immune Genes and Transcriptome towards Establishment of Virus Carrier State.
Journal: International journal of molecular sciences
Published: October 23, 2023
Malaria Vaccines: From the Past towards the mRNA Vaccine Era.
Journal: Vaccines
Published: July 23, 2023
Transcriptomic Analysis of Fish Hosts Responses to Nervous Necrosis Virus.
Journal: Pathogens (Basel, Switzerland)
Published: December 15, 2021
A Radioactive-free Kinase Inhibitor Discovery Assay Against the Trypanosoma brucei Glycogen Synthase Kinase-3 short (TbGSK-3s).
Journal: Bio-protocol
Published: October 17, 2019
Indirubin derivatives are potent and selective anti-Trypanosoma cruzi agents.
Journal: Virulence
Published: November 03, 2018
Last Updated: 09/26/2026